Cegedim announces a forward-looking partnership with Gustave Roussy to mark the 30th anniversary of its European real-world database, THIN

PRESS RELEASE

Cegedim announces a forward-looking partnership with Gustave Roussy to mark the 30th anniversary of its European real-world database, THIN

Paris, June 1, 2023 – As part of this new partnership, Cegedim, an innovative technology and services group which specializes in digital data flow management for healthcare ecosystems, will give Gustave Roussy, Europe’s leading cancer center, access to its anonymized patient database—THIN (The Health Improvement Network). THIN is one of Europe’s largest health databases, with the anonymized electronic health records of 69 million patients collected from general practitioners and specialists in seven European countries.

An innovative approach to support the fight against cancer

This partnership aims to train Gustave Roussy’s algorithms using THIN’s anonymized medical data collected in France and Europe by private practitioners with medical software.

Gustave Roussy will be able to explore THIN‘s anonymized data for over 69 million patients in Europe (patient characteristics, clinical outcomes, and medical history going back 5+ years per patient on average) to identify factors linked with the occurrence of cancers and develop or confirm hypotheses for prevention or treatment.

The approach is original because it supplements the methods Gustave Roussy already routinely uses in its genetic analyses to identify genes of interest among thousands of others.

Jean-Claude Labrune, Chairman of Cegedim, declared: “THIN provides access to accurate, ethical, actionable, anonymized, longitudinal patient data from a database whose objective is still the same 30 years on, namely, to foster and support medical progress. This partnership is a huge acknowledgement for all the private practitioners in France and Europe who help create this treasure trove, which is unique in the international scientific community.”

Dr. Suzette Delaloge, Director of the Interception program at Gustave Roussy, pointed out: “This partnership should enable us to develop new algorithms which will help identify people at high risk of developing cancers in general practice, so together we can move towards widespread personalized cancer prevention within a few years.”

THIN, a powerful and accurate European database that has been supporting research for 30 years

THIN Observatory’s goal is to collect anonymous patient data for use in research on medical practices and the prescription of drugs and treatment.

The THIN real-word database was started in 1993 with the recruitment of doctors in France and the United Kingdom alongside the rapid expansion of health informatics.